Atrium Therapeutics, Inc.
Expected move
No implied move.
Next report
Last report
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Atrium Therapeutics, Inc.
8.36
News
No implied move.
No implied move.
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Sessa Capital IMSessa Capital IM | $20.2M | 9.87% | +172.04% | |
| 2 | T. Rowe Price AssociatesT. Rowe Price | $19.8M | 9.69% | −5.17% | |
| 3 | BlackRockBlackRockindex-like | $19.5M | 9.52% | +20.09% | |
| 4 | Susquehanna International GroupSusquehanna International | $11.3M | 5.53% | −18.40% | |
| 5 | Vanguard Capital ManagementVanguardindex-like | $9.8M | 4.81% | +16.58% | |
| 6 | CrcmCrcm | $7.8M | 3.84% | new | |
| 7 | TIG AdvisorsTIG | $7.6M | 3.69% | −7.57% | |
| 8 | Geode Capital ManagementGeodeindex-like | $5.2M | 2.55% | +20.98% | |
| 9 | Two Sigma InvestmentsTwo Sigma | $4.6M | 2.27% | +93.48% | |
| 10 | Goldman Sachs GroupGoldman Sachs | $4.2M | 2.04% | −11.32% | |
| 11 | 683 Capital Management683 Capital Management | $4.0M | 1.97% | 0.00% | |
| 12 | State StreetState Streetindex-like | $3.7M | 1.79% | +5.71% | |
| 13 | Arbiter Partners Capital ManagementArbiter Partners | $3.5M | 1.72% | +13.60% | |
| 14 | Cantor Fitzgerald, L. P.Cantor Fitzgerald, L. P. | $3.5M | 1.69% | +9.03% | |
| 15 | Slotnik CapitalSlotnik Capital | $3.2M | 1.56% | +31.33% | |
| 16 | Weiss Asset ManagementWeiss | $3.0M | 1.45% | −8.71% | |
| 17 | Millennium ManagementMillennium | $2.7M | 1.32% | +5.08% | |
| 18 | Schonfeld Strategic AdvisorsSchonfeld Strategic | $2.7M | 1.31% | +22.36% | |
| 19 | AQR Capital ManagementAQR | $2.3M | 1.13% | new | |
| 20 | Highland Capital Management Fund AdvisorsHighland | $2.0M | 0.99% | 0.00% | |
| 21 | Polar Asset Management PartnersPolar Asset Management Partners | $2.0M | 0.99% | +114.29% | |
| 22 | Squarepoint OpsSquarepoint Ops | $2.0M | 0.97% | −36.60% | |
| 23 | Bracebridge CapitalBracebridge Capital | $1.9M | 0.92% | 0.00% | |
| 24 | Nomura HoldingsNomura | $1.8M | 0.90% | +0.01% | |
| 25 | Caption ManagementCaption | $1.8M | 0.90% | −33.42% |
155 managers report $204.4M of Atrium Therapeutics on form 13F for the quarter ended Jun 30 '26. 33 of them hold 80% of it; Sessa Capital IM is largest at 9.87%.